Literature DB >> 9048794

APOE genotyping and response to drug treatment in Alzheimer's disease.

F Richard, N Helbecque, E Neuman, D Guez, R Levy, P Amouyel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048794     DOI: 10.1016/S0140-6736(97)80089-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  The challenge of integrating genetic medicine into primary care.

Authors:  J Emery; S Hayflick
Journal:  BMJ       Date:  2001-04-28

2.  Expanding the role of the family history in primary care.

Authors:  J Emery; P Rose
Journal:  Br J Gen Pract       Date:  1999-04       Impact factor: 5.386

3.  Revalidation.

Authors:  M Pringle
Journal:  Br J Gen Pract       Date:  1999-04       Impact factor: 5.386

4.  Assessing the cost-effectiveness of pharmacogenomics.

Authors:  D L Veenstra; M K Higashi; K A Phillips
Journal:  AAPS PharmSci       Date:  2000

Review 5.  Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.

Authors:  J Poirier
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

Review 6.  ApoE-dependent plasticity in Alzheimer's disease.

Authors:  Bruce Teter
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Therapeutic approaches to age-associated neurocognitive disorders.

Authors:  R O'Hara; C Derouesné; K N Fountoulakis; J A Yesavage
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

8.  Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-05-29       Impact factor: 5.750

9.  A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease.

Authors:  Shan Jiang; Ling Tang; Na Zhao; Wanling Yang; Yu Qiu; Hong-Zhuan Chen
Journal:  Front Aging Neurosci       Date:  2016-07-12       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.